Petrolatum's Effect on Initial Symptoms of Nonscalp Seborrheic Dermatitis and Preventing Exacerbation

NCT01315951 | Terminated

• 1 other identifier: ME 10 0054
• Study Type: interventional
• Target: 3
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this research is to demonstrate the use of petroleum jelly in prevention of nonscalp seborrheic dermatitis exacerbations at the first signs of a flare. In doing so, it will decrease the chronic use of topical steroids. The use of petrolatum should have favorable outcomes for patients, without the side-effects.

Conditions

Seborrheic Dermatitis

Keywords

Non scalp Seborrheic Dermatitis

Outcome Measures

Primary Outcomes (1)

• Measuring the Effectiveness of Petroleum Jelly in Treating Nonscalp Seborrheic Dermatitis

  Petroleum jelly will be applied to the areas of the face affected by Nonscalp Seborrheic Dermatitis every other night for four weeks. Patients will be seen in the office at one week, two weeks, and one month during the course of the treatment. Pictures will be taken at each visit to determine the progress of the treatment.

  4 weeks

Secondary Outcomes (1)

• Patient Satisfaction ofTreatment

  4 weeks

Study Arms (1)

Petroleum Jelly

EXPERIMENTAL

Every patient will be applying petroleum jelly to the affected areas per protocol.

Biological: Petroleum Jelly

Interventions

Petroleum Jelly BIOLOGICAL

Every patient will be instructed to wet the affected area, blot dry, and then apply petroleum jelly to the area before bedtime. This regimen is to be followed every other night until symptoms diminish. The patient should follow-up at one week, two weeks, and four weeks after treatment begins to see the outcome.

Also known as: Petrolatum, Vaseline

Petroleum Jelly

Eligibility Criteria

• Age: 18 Years - 75 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Age 18-75 years old who are patients of the Genesys East Flint Clinic and have been diagnosed with recurrent NSSD
• Patients are to use the petrolatum treatment strictly for the initial symptoms of NSSD: Excessive flaking, and erythematous macules or papules
• Patients who are able to attend the follow-up appointments for assessment
• Patients are to have the doctor's confidence that that patient will correctly implement the treatment plan

You may not qualify if:

• Patients not in the 18-75 years of age range.
• Patients who are receiving treatment for their seborrheic dermatitis (Scalp or nonscalp) elsewhere.
• Patients who have not demonstrated recurrent NSSD.
• Patients who are unable to commit to a follow-up appointments for assessment.
• Patients who do not have the physician's confidence in implementing the studies treatment plan effectively.
• Patient's who are unable/unwilling to have petrolatum on affected area for at least a 6 hour length of time.

Sponsors & Collaborators

• Ascension Health: lead

Study Sites (1)

Genesys East Flint Campus

Burton, Michigan, 48509, United States

Location

MeSH Terms

Conditions

Dermatitis, Seborrheic

Interventions

Petrolatum

Condition Hierarchy (Ancestors)

Dermatitis; Skin Diseases; Skin and Connective Tissue Diseases; Sebaceous Gland Diseases; Skin Diseases, Eczematous; Skin Diseases, Papulosquamous

Intervention Hierarchy (Ancestors)

Hydrocarbons; Organic Chemicals

Study Officials

• Ryan D Stevenson, BS

  Ascension Health

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Director research integrity and compliance

Study Record Dates

• First Submitted: March 15, 2011
• First Posted: March 16, 2011
• Study Start: March 1, 2011
• Primary Completion: February 1, 2012
• Study Completion: March 1, 2012
• Last Updated: May 20, 2024

Record last verified: 2024-05

Locations

US (1)